The Tech, Tools and Diagnostics Driving Advancements in Precision Medicine
Browse the Marketplace below, or view the digital edition of the comprehensive 2020 Insider’s Guide
Welcome to the Clinical OMICs Marketplace, the industry’s only guide to the technologies and tools advancing precision medicine. Find the solutions to your challenges, drive innovation in your research & development, and close the gap from bench to bedside – get started now.
Marketplace > Oncology > Liquid Biopsy > QIAseq Targeted Methyl Panels (QIAGEN)

QIAseq Targeted Methyl Panels (QIAGEN)

A liquid biopsy-compatible solution for targeting methylation status of DNA, from as low as 1 ng input DNA from cells and tissues, or 10 ng from FFPE samples and liquid biopsies.

QIAseq Targeted Methyl Panels offer a single-day solution capable of targeting thousands of CpG sites in the genome. As with targeted DNA panels, QIAseq solutions are based on single-primer extension (SPE) technology that provides a sensitive and specific solution for detecting regions all across the genome.


19300 Germantown Road
Germantown, MD 20874

REQUEST INFO: QIAseq Targeted Methyl Panels (QIAGEN)

  • Complete system to go from bisulfite-converted DNA to a sequencing-ready library using a single-day workflow
  • Error correction with Unique Molecular Indices (UMIs) to enhance NGS panel sensitivity
  • A single-primer extension (SPE) approach that increases sensitivity and overcomes targeting challenges compared to other NGS technologies
  • Integrated Sample to Insight analysis solutions with cloud-based QIAGEN GeneGlobe or locally-installed QIAGEN CLC Genomics Workbench software

QIAseq Targeted Methyl Panels (QIAGEN)

Scroll Up

Want to learn more about this product?

Request additional information now.


Download the digital edition of the comprehensive 2020 Insider’s Guide